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BACKGROUND: We evaluated associations between perceived social support, social integration, living alone, and colorectal cancer 
(CRC) outcomes in postmenopausal women. METHODS: The study included 1431 women from the Women’s Health Initiative who were 
diagnosed from 1993 through 2017 with stage I through IV CRC and who responded to the Medical Outcomes Study Social Support sur-
vey before their CRC diagnosis. We used proportional hazards regression to evaluate associations of social support (tertiles) and types 
of support, assessed up to 6 years before diagnosis, with overall and CRC-specific mortality. We also assessed associations of social 
integration and living alone with outcomes also in a subset of 1141 women who had information available on social ties (marital/partner 
status, community and religious participation) and living situation. RESULTS: In multivariable analyses, women with low (hazard ratio 
[HR], 1.52; 95% CI, 1.23-1.88) and moderate (HR, 1.21; 95% CI, 0.98-1.50) perceived social support had significantly higher overall mortality 
than those with high support (P [continuous] < .001). Similarly, women with low (HR, 1.42; 95% CI, 1.07-1.88) and moderate (HR, 1.28; 95% 
CI, 0.96-1.70) perceived social support had higher CRC mortality than those with high social support (P [continuous] = .007). Emotional, 
informational, and tangible support and positive interaction were all significantly associated with outcomes, whereas affection was not. 
In main-effects analyses, the level of social integration was related to overall mortality (P for trend = .02), but not CRC mortality (P for
trend = .25), and living alone was not associated with mortality outcomes. However, both the level of social integration and living alone
were related to outcomes in patients with rectal cancer. CONCLUSIONS: Women with low perceived social support before diagnosis 
have higher overall and CRC-specific mortality. Cancer 2020;126:1766-1775. © 2020 American Cancer Society. 
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INTRODUCTION
Social support is the perception and reality of the exchange of assistance through social relationships.1 Social networks 
(SNs) are defined as the web of social ties that surround an individual1; SN size and social integration, defined as the 
degree to which people are engaged with society, are often used interchangeably. Social isolation is defined as few SN 
ties or little contact with those ties, although living alone has often been used as a proxy in research and in clinical care 
settings. SNs, social ties, social integration, and social isolation are measures of structural social support, whereas social 
support, also called functional social support, may be provided through SNs.2
Substantial literature has demonstrated that women with larger SNs and greater social support have longer breast cancer 
survival.3-8 Although colorectal cancer (CRC) is the third most common cancer in the United States, and social support 
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is considered to have an important influence on cancer 
survival generally,2 exceedingly little work has examined 
the influence of social support on CRC outcomes. This is 
caused in part by the lack of large CRC cohorts with social 
data and sufficient follow-up to examine social variables 
and mortality outcomes. In a study of 294 patients, 26% 
of whom had CRC, social ties and social support were 
unrelated to survival in the combined subset of patients 
who had lung cancer and CRC.9 In the Nurses’ Health 
Study (NHS) (N = 896), women who were more socially 
integrated had longer CRC survival; however, there was 
no association between the presence of a confidant, the 
investigators’ proxy measure of social support, and CRC 
survival.10 Being married has been associated with bet-
ter survival in patients with CRC.11-15 Living alone was  
associated with worse survival in Scandinavian patients 
with metastatic CRC.16 Although associations of social 
support, SNs, and CRC outcomes might parallel asso-
ciations seen in patients with breast cancer, associations 
may differ by type of cancer. Differences may be due to 
differential types and invasiveness of treatment, needs for 
support, and caregiving burdens among those who pro-
vide support,17 particularly given findings showing large 
declines in support in a substantial fraction of patients 
with CRC in the 2 years after diagnosis related to patient 
comorbidities or a stoma.17
Therefore, we examined associations of social sup-
port using the well established Medical Outcomes Study 
(MOS) social support measure and CRC survival (over-
all and disease-specific mortality) in a large population 
of postmenopausal women from the Women’s Health 
Initiative (WHI). Specifically, we examined how wom-
en’s reserves of support before diagnosis may influence 
CRC outcomes. We also examined associations of social 
ties and living status with outcomes and further exam-
ined whether factors such as disease severity, depressive 




The design of the WHI has been previously 
described.18,19 Briefly, the WHI observational study is 
a multiethnic cohort of 93,676 postmenopausal 
women, ages 50 to 79 years, who were enrolled 
during 1993 through 1998 at 40 geographically 
diverse clinical centers throughout the United States. 
Eligibility criteria included: 1) ages 50 to 79 years, 2) 
postmenopausal status, 3) willingness to provide 
informed consent, and 4) at least a three-year life 
expectancy. The WHI clinical trials study includes 
68,132 
women with the same basic eligibility who agreed to par-
ticipate in randomized clinical trials of diet or menopau-
sal hormone therapy. Recruitment methods are detailed 
elsewhere.20
We selected into the cohort women who were 
diagnosed with any stage primary CRC between study 
enrollment and study end in February 2017 (n = 2906) 
who completed social measures within 6  years before 
CRC diagnosis (N = 1858). To clarify, women from the 
WHI provided information on social measures at 3 time-
points; women from both the observational study and the 
clinical trials study provided information at study base-
line and again in 2011 and 2012 for those who agreed 
to participate in the WHI Extension Study II. Women 
from the clinical trials study also completed social mea-
sures at the close of the initial WHI study, approxi-
mately 10 years after the baseline assessment. This meant 
that the cohort consisted of 3 WHI subcohorts—those 
diagnosed within 6 years after baseline (N = 903), study 
closeout (N = 291), or the Extension Study II (N = 237). 
The cutoff point of 6  years was chosen to balance the 
tradeoff in maximizing the number of participants in the 
study and selecting patients with social support measures 
close in time and before diagnosis. Of these, we excluded 
women with a history of cancer, except for nonmelanoma 
skin cancer (N  =  281), those missing information on 
stage or grade (N =  90), and those specifically missing 
the MOS social support measure (N  =  56). Thus we 
included 1431 women in the study population (mean age, 
72 years). Follow-up after a CRC diagnosis ranged from 
0 to 21.9  years (median follow-up, 5.8  years). During 
follow-up, 539 women died, including 327 from CRC. 
Human subjects review committees at each participating 
institution approved the protocol, and all participants 
provided written informed consent.
Data Collection
At baseline, participants provided detailed informa-
tion about demographics, psychosocial factors, medical 
history, and known or suspected risk factors for cancer 
through a self-administered questionnaire. This informa-
tion included self-reported race/ethnicity and socioeco-
nomic status (education, income). Social and psychosocial 
measures were collected at additional timepoints, as pre-
viously described. Medical history was updated annually 
in the observational study and every 6  months in the 
clinical trials study (annually in the clinical trials study 
after 2005), by mail and/or telephone questionnaires. 
Lifestyle measures (ie, smoking, physical activity, alco-
hol consumption) were assessed by survey at baseline, 
in year 9 (among clinical trials study participants), and 
at year 2 of Extension Study II. Anthropometric meas-
ures were collected yearly in clinical trials study partici-
pants and at baseline and year 3 in observational study 
participants. Aspirin and ibuprofen use was assessed by 
in-person interviews. Age at diagnosis and disease sever-
ity (stage, grade, site) were assessed at the time of CRC 
diagnosis. Treatment data (surgery, radiotherapy, and 
chemotherapy), collected through the Life and Longevity 
After Cancer (LILAC) study of women from the WHI  
diagnosed with cancer, used Medicare data in women 
who were diagnosed at ages ≥65 years, medical records 
in those who died before the LILAC study, and a combi-
nation of medical records and self-reported data in those 
living participants with CRC.21 Treatment data were 
available for 67.5% of women in the study population.
CRC ascertainment
Cancers were initially identified from annual self-report 
of medical history and then confirmed by medical record 
and pathology report review (available in 98.2% of partic-
ipants). All cancers were centrally adjudicated, and char-
acteristics (histology, stage, grade, and site) were coded 
using the Surveillance, Epidemiology, and End Results 
coding system.22 These analyses were limited to invasive 
CRCs that were confirmed by central review.
Mortality
Attribution of cause of death was based on medical record 
review by physician adjudicators who were blinded to  
information about SNs.22 The National Death Index was 
searched at 2-year to 3-year intervals to identify deaths in 
participants who were lost to follow-up. For CRC cases 
identified only through the National Death Index, infor-
mation was limited to death certificates only.
Social support
Social support was assessed within 6  years before diag-
nosis using 9 items from the MOS questionnaire.23 
On a 5-point scale, participants ranked how often spe-
cific types of support, including emotional support (eg, 
someone to listen to problems), affection (eg, someone 
to make a person feel loved), tangible support (eg, help 
with chores or rides to the doctor), and positive inter-
action (eg, someone to have fun with), were available. 
The summary score ranged from 9 to 45 (mean  ±  SD 
score, 36.0 ± 8.0), with a higher score indicating more 
social support. Internal consistency for the score was high 
(standardized Cronbach α = .94). No clinically meaning-
ful categories exist for the MOS social support scale,24  
so we categorized social support into tertiles based on the 
distribution of women in this study.
Social integration (SN size) and social ties
SN members (social ties) included a spouse or intimate 
partner, club ties, and religious ties. Women were asked, 
“Are you currently married or in an intimate relationship 
with at least 1 person?” Women were also asked, “How 
often have you gone to meetings of clubs, lodges, or par-
ent groups in the last month?” and, “How often have you 
gone to a religious service or to church during the past 
month?” For these questions, response options included: 
1) not at all in the past month, 2) once in the past month,
3) 2 or 3 times in the past month, 4) once a week, 5) 2
to 6 times a week, and 6) every day. To compute a proxy
variable for SN size (ie, our measure of social integration),
we dichotomized and summed variables (any [scored 1] vs
no [scored 0] religious participation, any [scored 1] vs no
[scored 0] community participation, and married/part-
nered [scored 1] or not [scored 0]) and categorized the
resulting variable into 3 groups of similar size. Those with
the largest networks were categorized as socially integrated,
those in the middle group were categorized as moderately
integrated, and those with the smallest networks were cat-
egorized as socially isolated. We also analyzed each social
tie separately.
Living status
Women were asked whether they lived alone or with a 
family member, friend, or pet. We specifically focused 
on whether women lived alone versus with (an)other 
person(s).
Covariates
Study (clinical trials study vs observational study) was 
determined at baseline. We computed lag time as the 
time between social assessment and CRC diagnosis. 
Family history of CRC, lifestyle and related factors 
(body mass index [BMI], alcohol, physical activity, 
smoking, aspirin/ibuprofen intake), depressive symp-
toms, and comorbidity, using the WHI-modified 
Charlson index,25 were assessed closest in time to social 
measures. Depressive symptoms were assessed using the 
Centers for Epidemiologic Studies Depression scale.26 
Alcohol was measured in drinks per week, and smoking 
was assessed as current, past, or never. Physical activity 
was assessed in terms of hours per week of moderate 
or strenuous physical activity, and weekly recreational 
physical activity was calculated by multiplying an as-
signed energy expenditure level for each category of 
activity by the hours exercised per week to calculate 
total metabolic equivalents per week.27 BMI (in kg/m2) 
was derived from information on weight and height. 
Women also provided information on CRC screen-
ing (colonoscopy/sigmoidoscopy, fecal occult blood 
test, barium enema) at 6-month (clinical trials study) 
or annual (observational study) medical updates; and 
the information obtained closest to each social meas-
ure was used. Aspirin and ibuprofen use was assessed 
dichotomously (yes/no) using a single indicator varia-
ble. Hormone therapy use was assessed at baseline using 
a single indicator.
Statistical Analyses
We evaluated frequencies or means of variables by ter-
tiles of social support using chi-square and Wald tests 
(Table 1).
TABLE 1. Characteristics of Patients With 




Pc High Moderate Low
Total no. 485 486 460
WHI baseline characteristics, %
Observational study 
participants
41.4 42.8 42.4 .91
Family history of CRC, 
N = 1311
19.2 21.9 22.7 .41
Hormone use, N = 1429
Never 77.3 79.8 80.4 .49
Past 7.2 7.0 5.0
Current 15.5 13.2 14.6
Demographic characteristics, %
Ethnicity
Caucasian 85.8 81.3 82.4 .87
African American 8.7 11.9 10.2
Asian 2.3 2.5 2.4
Hispanic/Latino 1.7 2.3 2.8
Other/unknown 1.7 2.1 2.1
Education, N = 1420




College graduate 12.1 11.8 11.6
Postgraduate 22.0 24.4 25.4
Household income, N = 1350
<$25,000 13.7 17.1 27.8 <.001
$25,000-$49,999 48.7 48.1 46.1
≥$50,000 37.6 34.9 26.2
Characteristics at time of 
diagnosis
Age at diagnosis, y 72.0 72.1 72.2 .90
Time from social measure to 
diagnosis, d
1052 1027 1000 .40




33.8 35.0 31.7 .93


















Grading unknown 11.6 9.7 12.0
Site, %
Colon cancer 80.8 82.1 82.0 .87
Rectal cancer 13.0 13.2 12.2
Unknown 6.2 4.7 5.9
Surgery, %
Yes 65.0 68.7 58.5 .03
No 5.4 4.7 6.7
Unknown 29.7 26.5 34.8
Chemotherapy, %
Yes 27.0 29.8 25.0 .11
No 40.8 42.2 38.9
Unknown 32.2 28.0 36.1
Characteristic
Social Supportb 
Pc High Moderate Low
Radiation, %
Yes 4.3 6.8 4.6 .05
No 63.9 65.0 59.1
Unknown 31.8 28.2 36.3
Characteristics closest to social 
measures
Social support rangeb 9-34 34-41 41-45
Any comorbidity, % 22.5 28.0 26.3 .13
Depressive symptomatology 
score, N = 1430, %




42.1 48.9 47.9 .09
Moderate/strenuous  
exercise, N = 1289
0 h/wk 52.3 53.9 57.0 .03
1-2 h/wk 16.4 21.1 20.7
≥3 h/wk 31.3 25.0 22.3
Smoking, N = 1407
Never 71.6 65.7 59.6 <.001
Past 25.9 30.1 32.1
Current 2.5 4.2 8.4
BMI, N = 1379
<25 kg/m2 31.6 30.6 30.2 .86
25 to <30 kg/m2 34.6 36.8 34.2
≥30 kg/m2 33.8 32.6 35.6
Alcohol intake, N = 1421
None/past 33.5 34.0 33.6 .69
1 to <7 drinks or d/wk 53.4 55.2 56.1
Daily or >7 d 13.1 10.8 10.3
Recent aspirin or ibuprofen 
use
14.9 17.5 17.0 .50
Abbreviations: BMI, body mass index; CRC, colorectal cancer; WHI, Women’s 
Health Initiative.
aThere were 1431 study participants unless otherwise indicated.
bValues shown indicate tertiles of social support using the Medical Outcomes 
Study social support measure.
cP values were determined using the chi-square test or the Wald test.
TABLE 1. Continued
Analyses of social variables 
and mortality outcomes
We used Cox proportional hazards models (SAS PROC 
PHREG, SAS version 9.4; SAS Institute Inc) for failure-
time data to assess associations of social support, types 
of social support, social integration, social ties, and liv-
ing status with the time to overall mortality and disease-
specific mortality,28,29 considering the competing risks 
of mortality from other causes. Although a key interest 
was to examine CRC-specific mortality, we examined 
all-cause mortality both because examination of this out-
come overcomes concerns about bias in the assignment 
of cause and because overall mortality is an important 
outcome in and of itself. Person-years of follow-up were 
measured from the date of diagnosis until the date of 
death, loss to follow-up, or the end of follow-up, which-
ever came first. We conducted tests for linear trend using 
continuous variables and computed Wald statistics.
Minimally-adjusted models were adjusted for age at 
diagnosis, race/ethnicity, study arm (clinical trials study 
vs observational study), time between social assessment 
and CRC diagnosis, stage, and grade (model 1). Because 
of strong overlap between stage and grade, we combined 
these variables into a single variable; categories with similar 
mortality risk were further combined. We also generated 
cumulative mortality curves for minimally adjusted asso-
ciations of social support and overall and disease-specific 
mortality outcomes. Analyses in model 2 were adjusted 
additionally for family history of CRC, education, in-
come, comorbidity, and cancer site. Covariates included 
those that were considered a priori to be important 
potential confounders of the association between SNs and 
CRC mortality.
We considered separate models to determine whether 
1) depressive symptoms, 2) treatment (surgery, chemo-
therapy, radiotherapy), or 3) lifestyle/behavioral factors
(alcohol, BMI, exercise, smoking, aspirin or ibuprofen use,
hormone therapy at baseline, CRC screening) mediated
associations. However, given few differences in the  results
between mediation models, we presented one model that
was adjusted for all possible mediators (model 3). We
 allowed missing categories for covariates in the analyses.
Stratified analyses
We evaluated effect modification by age (< or ≥ median = 
72.3 years) at diagnosis, race/ethnicity (non-Latina white 
or not non-Latina white), education (less than a college de-
gree vs a college degree or greater), family history of CRC 
(no, yes), stage (in situ/local vs regional/distant), pres-
ence of comorbidity (no, yes), cancer site (colon, rectal), 
Figure 1. Cumulative total mortality is illustrated among 1431 participants from the Women's Health Initiative who were diagnosed 
with colorectal cancer, by tertile of social support. The model is adjusted for age at diagnosis (continuous), time between social 
assessment and diagnosis (continuous), race/ethnicity (non-Hispanic white [reference category], African-American, Asian/Pacific 
Islander, Hispanic, other), and stage and grade (local [reference category], regional, distant and well differentiated/moderately 
differentiated, distant and nondifferentiated/anaplastic).
Figure 2. Cumulative colorectal-specific cancer mortality is illustrated among 1431 participants from the Women's Health Initiative 
who were diagnosed with colorectal cancer, by tertile of social support. The model is adjusted for age at diagnosis (continuous), time 
between social assessment and diagnosis (continuous), race/ethnicity (non-Hispanic white [reference category], African-American, 
Asian/Pacific Islander, Hispanic, other), and stage and grade (local [reference category], regional, distant and well differentiated/
moderately differentiated, distant and nondifferentiated/anaplastic).
TABLE 2. Relative Hazards of Mortality by Level of Social Support Among Women in the Women's Health 
Initiative Diagnosed With Colorectal Cancer, N = 1431
Characteristic
Social Supporta 
Pb High Moderate Low
No. of women 485 486 460
Social support, range 9-34 34-41 41-45
Overall mortality, no. 183 205 228
Model 1: HR (95% CI)c 1.00 1.20 (0.97-1.49) 1.49 (1.20-1.83) <.001
Model 2: HR (95% CI)d 1.00 1.21 (0.98-1.50) 1.52 (1.23-1.88) <.001
Model 3: HR (95% CI)e 1.00 1.17 (0.94-1.46) 1.42 (1.14-1.77) .003
CRC-specific mortality, no. 119 138 142
Model 1: HR (95% CI)c 1.00 1.24 (0.94-1.64) 1.36 (1.03-1.80) .01
Model 2: HR (95% CI)d 1.00 1.28 (0.96-1.70) 1.42 (1.07-1.88) .007
Model 3: HR (95% CI)e 1.00 1.27 (0.96-1.69) 1.37 (1.02-1.84) .01
Abbreviations: CRC, colorectal cancer; HR, hazard ratio.
aValues shown indicate tertiles of social support using the Medical Outcomes Study social support measure.
bP values were used from continuous measures of social support.
cModel 1 was a minimally adjusted model and was adjusted for age at diagnosis (continuous), time between social assessment and diagnosis (continuous), study 
(clinical trial, observational study), race/ethnicity (non-Hispanic white [reference category], African-American, Asian/Pacific Islander, Hispanic, other), and stage and 
grade (local [reference category], regional, distant and well differentiated/moderately differentiated, distant and nondifferentiated/anaplastic).
dModel 2, which included possible confounding variables, was adjusted for the covariates in model 1 and additionally for site (rectal, colon [reference category]), 
education (<high school, high school, some college, college degree or greater [reference category]), income (<$20,000, $20,000 to <$50,000, ≥$50,000 [reference 
category]), family history of colorectal cancer (yes, no [reference category]), and comorbidity (yes, no [reference category]).
eModel 3, which considered mediation by depressive symptoms and treatment and lifestyle factors, was adjusted for the covariates in model 2 and was also ad-
justed for surgery (yes, no [reference category]), chemotherapy (yes, no [reference category]), radiation (yes, no [reference category]), colorectal cancer screening 
(yes, no [reference category]), depressive symptomatology (continuous), aspirin or ibuprofen use (yes, no [reference category]), use of hormone therapy (yes, no [ref-
erence category]), alcohol intake (none [reference category], >0 to <1.7, 1.7 to <15, ≥15 g/day), smoking (never [reference category], past, current), physical activity 
(0 to <10 [reference category], 10 to <20, ≥20+ metabolic equivalents per week), and body mass index (<18.5, 18.5-25 [reference category]), 25-<30, ≥30 kg/m2).
smoking behavior (ever vs never), social strain (<median 
vs ≥median), and provision of caregiving (no, yes). When 
associations differed across strata, we used Wald tests to 
evaluate interaction terms of dichotomous stratification 
variables and either continuous or dichotomous variables, 
as indicated. All statistical tests were 2-sided, and the cri-
terion for statistical significance was P < .05.
RESULTS
Women with low levels of support reported lower income 
levels, were more likely to be current smokers, and had 
greater depressive symptomatology. However, levels of 
social support were unrelated to age at diagnosis, lag time 
between social measure to diagnosis, race/ethnicity, edu-
cation, study arm, family history of CRC, comorbidity, 
cancer site, stage, tumor grade, CRC screening, use of hor-
mone therapy, aspirin/ibuprofen use, BMI, alcohol use, 
moderate/strenuous physical activity, or BMI (Table 1).
Main-Effects Analyses
In minimally adjusted (Figs. 1 and 2, Table 2) and 
multivariable-adjusted (Table 2) models, women with 
low levels of social support had higher overall mortal-
ity (hazard ratio [HR], 1.52; 95% CI, 1.23-1.88) and 
CRC-specific mortality (HR, 1.42; 95% CI, 1.07-1.88). 
In Figure 1, overall mortality curves reveal a consistent 
separation across social support categories over follow-up. 
In Figure 2, we note a large separation between those who 
had high support versus those who had low or moder-
ate support in terms of CRC-specific mortality, with the 
steepest rise in mortality observed during the first 5 years 
after diagnosis. In associations adjusted for possible medi-
ating factors, associations with overall and CRC mortality 
were only slightly attenuated (Table 2). Regarding specific 
types of social support, tangible, emotional, and informa-
tional support, as well as positive interaction were each 
inversely related to outcomes; affection, however, was un-
related to outcomes (Supporting Table 1).
In analyses of social ties and outcomes, the level of 
social integration was associated with overall (P [continu-
ous] = .02), but not CRC-specific (P [continuous] = .25), 
mortality regardless of adjustment for covariates or pos-
sible mediators (Table 3). Looking separately by type of 
social tie, each tie contributed to the overall association 
with overall mortality, but associations were weak and 
mostly nonsignificant. Living alone was associated with 
overall, but not CRC-specific, mortality in minimally 
adjusted models. After multivariable adjustment, living 
alone was no longer associated with outcomes regardless 
of the level of adjustment (Supporting Table 2).
TABLE 3. Relative Hazards of Mortality by Level of Social Integration Among Women in the Women's Health 
Initiative Diagnosed With Colorectal Cancer, N = 1143
Characteristic
Level of Social Integrationa 
Pb Socially Integrated Moderately Integrated Socially Isolated
No. of women 273 494 374
Overall mortality, no. 96 203 170
Model 1: HR (95% CI)c 1.00 1.20 (0.94-1.54) 1.36 (1.05-1.76) .007
Model 2: HR (95% CI)d 1.00 1.18 (0.92-1.52) 1.32 (1.01-1.71) .02
Model 3: HR (95% CI)e 1.00 1.14 (0.89-1.48) 1.27 (0.97-1.66) .03
CRC-specific mortality, no. 59 135 98
Model 1: HR (95% CI)c 1.00 1.16 (0.86-1.58) 1.22 (0.88-1.68) .18
Model 2: HR (95% CI)d 1.00 1.20 (0.88-1.64) 1.21 (0.87-1.69) .25
Model 3: HR (95% CI)e 1.00 1.07 (0.78-1.46) 1.14 (0.81-1.61) .33
Abbreviations: CRC, colorectal cancer; HR, hazard ratio.
aLevels of social integration are indicated in approximate tertiles (for a description of the measure for social integration, see Social integration [social network size] 
and social ties).
bP values were used from continuous measures of social integration.
cModel 1 was a minimally adjusted model adjusted for age at diagnosis (continuous), time between social assessment and diagnosis (continuous), study (clinical 
trial, observational study), race/ethnicity (non-Hispanic white [reference category], African-American, Asian/Pacific Islander, Hispanic, other), and stage and grade 
(local [reference category], regional, distant and well differentiated/moderately differentiated, distant and nondifferentiated/anaplastic).
dModel 2, which included possible confounding variables, was adjusted for the covariates in model 1 and additionally for site (rectal, colon [reference category]), 
education (<high school, high school, some college, college degree or greater [reference category]), income (<$20,000, $20,000 to <$50,000, ≥$50,000 [reference 
category]), family history of colorectal cancer (yes, no [reference category]), and comorbidity (yes, no [reference category]).
eModel 3, which considered mediation by depressive symptoms and treatment and lifestyle factors, was adjusted for the covariates in model 2 and was also ad-
justed for surgery (yes, no [reference category]), chemotherapy (yes, no [reference category]), radiation (yes, no [reference category]), colorectal cancer screening 
(yes, no [reference category]), depressive symptomatology (continuous), aspirin or ibuprofen use (yes, no [reference category]), use of hormone therapy (yes, no [ref-
erence category]), alcohol intake (none [reference category], >0 to <1.7, 1.7 to <15, ≥15 g/day), smoking (never [reference category], past, current), physical activity 
(0 to <10 [reference category], 10 to <20, ≥20+ metabolic equivalents per week), and body mass index (<18.5, 18.5-25 [reference category]), 25-<30, ≥30 kg/m2).
Stratified Analyses
We noted little evidence of effect modification by edu-
cation, family history of CRC, or caregiving. Although 
there was some evidence for effect modification by age 
at diagnosis, race/ethnicity, smoking, comorbidity, stage, 
and social strain, inconsistencies in findings for each social 
variable and type of outcome, as well as the small size of 
particular strata, made these differences difficult to inter-
pret (data not shown). However, living alone appeared 
to be related more strongly to overall (P for interac-
tion =  .02) and CRC-specific (P for interaction =  .03) 
mortality in patients with rectal cancer (Table 4). SN size 
also appeared to be more strongly related to outcomes in 
those with rectal cancer (Table 4).
DISCUSSION
In this large study of postmenopausal women from the 
WHI who were diagnosed with CRC, those with low 
social support had higher rates of disease-specific and 
overall mortality than those with high levels of social 
support. Associations were independent of demographic 
factors, socioeconomic status, disease severity, depres-
sive symptomatology, and lifestyle/behavioral factors. In 
main-effects analyses, SN size was associated with overall, 
but not CRC, mortality, and living alone did not predict 
either overall or CRC mortality. Social isolation and liv-
ing alone appeared to be more strongly related to overall 
and CRC-specific mortality in patients with rectal cancer 
versus colon cancer. Our findings provide evidence that 
women with high levels of social support have longer 
CRC survival than women with low levels of social sup-
port. To our knowledge, this is the largest prospective 
study to date examining associations of social support, 
SNs, living situation, and CRC survival.
Limited work has evaluated social support, social 
ties, and CRC survival, although a growing number of 
studies suggest the importance of these factors in predict-
ing CRC mortality. Being married has been associated 
with better survival in patients with CRC.11-15 In 896 
women with CRC (mean age at diagnosis, 70 years) from 
the NHS, a large, longitudinal observational study, Sarma 
and colleagues10 found that those who were socially inte-
grated before diagnosis had lower rates of all-cause mor-
tality (HR, 0.65; 95% CI, 0.46-0.92) and CRC-specific 
mortality (HR, 0.63; 95% CI, 0.38-1.06) compared with 
women who were socially isolated. Social integration was 
assessed before CRC diagnosis using the Berkman-Syme 
SN index. By contrast, social support, assessed as the 
presence of a confidant, was unrelated to CRC survival. 
In 2835 women with breast cancer from the NHS, 
Kroenke et al reported parallel findings.3 Specifically, 
women who were socially isolated had higher overall 
mortality (HR, 1.66; 95% CI, 1.04-2.65) and breast 
cancer-specific mortality (HR, 2.14; 95% CI, 1.11-
4.12) compared with those who were socially integrated, 
whereas social support, also assessed as the presence 
of a confidant, was unrelated to breast cancer survival. 
Kroenke and colleagues replicated findings for SN size 
and overall and breast cancer mortality in 9267 patients 
from the After Breast Cancer Pooling Project30 but did 
not examine social support and outcomes. Ell and col-
leagues also found no association of emotional support 
and CRC and lung cancer (combined) survival, but their 
study included only 76 patients with CRC.
The apparent relevance of structural or functional 
social supports to CRC survival and thus differences in 
TABLE 4. Relative Hazards of Mortality Among 
Women In the Women's Health Initiative Diagnosed 
With Colorectal Cancer, by Cancer Sitea 
Characteristicb 
HR (95% CI)
Colon Cancer Rectal Cancer
No. of women 1168 183
Overall mortality, no. 445 68
Level of social integration
Socially integrated 1.00 1.00
Moderately integrated 1.25 (0.96-1.63) 1.82 (0.82-4.06)
Socially isolated 1.32 (1.00-1.74) 2.61 (1.15-5.92)
P for trend .05 .006
P for interaction .29
Living situation
Lives with someone 1.00 1.00
Lives alone 0.98 (0.79-1.22) 1.81 (1.01-3.25)
P-value .87 .05
P for interaction .02
CRC-specific mortality, no. 273 41
Level of social integration
Socially integrated 1.00 1.00
Moderately integrated 1.25 (0.89-1.75) 2.28 (0.83-6.26)
Socially isolated 1.28 (0.89-1.84) 3.43 (1.17-10.0)
P for trend .22 .05
P for interaction .65
Living situation
Lives with someone 1.00 1.00
Lives alone 0.93 (0.70-1.24) 1.76 (0.77-4.01)
P for trend .61 .18
P for interaction .03
Abbreviations: CRC, colorectal cancer; HR, hazard ratio.
aNo difference was observed in the association between social support and 
outcomes by cancer site.
bModels were adjusted for age at diagnosis (continuous), time between so-
cial assessment and diagnosis (continuous), study (clinical trial, observational 
study), race/ethnicity (non-Hispanic white [reference category], African-
American, Asian/Pacific Islander, Hispanic, other), and stage and grade (local 
[reference category], regional, distant and well differentiated/moderately 
differentiated, distant and nondifferentiated/anaplastic), site (rectal, colon 
[reference category]), education (<high school, high school, some college,
college degree or greater [reference category]), income (<$20,000, $20,000 to 
<$50,000, ≥$50,000 [reference category]), family history of colorectal cancer 
(yes, no [reference category]), and comorbidity (yes, no [reference category]).
study findings30 appear to be caused by differences in 
study measures, characteristics of study populations, 
type of cancer, cancer site, and outcome. Given the 
use of a well established, validated measure of social 
support, our findings are more likely than prior stud-
ies to provide an accurate estimate of associations. In 
our study, levels of social support, particularly tangible, 
emotional, and informational support, and positive in-
teraction, were important predictors of CRC outcomes. 
By contrast, the presence of an emotional confidant, 
which was used in the NHS, is not a well established 
or validated measure of objective or perceived social 
support.
It is conceivable that we might have observed a 
stronger association of SN size and CRC-specific mor-
tality if we had had data on close family and friends, 
which were the major predictors of cancer mortality in 
the NHS.3,10 SN size was nonetheless related to dis-
ease-specific mortality in patients with rectal cancer 
and in never-smokers in our study, suggesting that SNs 
may confer differential benefits, depending on cancer 
site or type of cancer, and/or that certain SNs are more 
salutary than others. Living alone, although not associ-
ated with mortality outcomes in main-effects analyses, 
was also more strongly related to outcomes in patients 
with rectal cancer, providing additional evidence that 
structural support measures matter for rectal cancer 
outcomes. Although healthy individuals, who may also 
be more likely to sustain extraspousal and extrafamilial 
SNs, may be more likely to live alone,31 living alone 
can augment mortality risk in individuals with lim-
ited social ties and mobility issues,32 and living alone 
has been associated with lower treatment intensity and 
poorer survival in patients with metastatic CRC.16 Thus 
the potential risk conferred by living alone may be situ-
ation-dependent, and the overall association could be a 
result of mixed effects. Further work is needed to repli-
cate findings in a larger sample of patients, particularly 
in patients with rectal cancer given the relatively small 
number of those patients in the current study. Further 
work is also needed to explore whether associations dif-
fer in patients with distal or proximal colon cancers.
Strengths of the current study included the large 
sample size, prospectively collected data, the use of a 
well established measure of social support, consideration 
of competing risks, and an extensive set of covariates, 
enabling adjustment for disease severity, socioeconomic 
status, and several potential mediating factors. This study 
included social measures before diagnosis, enabling the 
assessment of social support unaffected by diagnosis. 
Study limitations included a lack of information on treat-
ment for one-third of study participants, a lack of data 
on patient stomas, and limited numbers of patients with 
rectal cancer or comorbidities. A potential concern is the 
inclusion of those who had missing values for covariates, 
especially for treatment data. However, when we restricted 
our analyses to patients without missing data, associations 
were qualitatively similar (data not shown). Future stud-
ies should include greater representation of women from 
racial/ethnic minority groups and women of lower socio-
economic status.
Further research is also needed to elucidate explana-
tory mechanisms, given that adjustment for potential me-
diators did not explain associations. Social support may 
improve outcomes in other ways, such as through ben-
eficial informal caregiving or physiologic intermediates 
like inflammatory biomarkers,33 factors we were unable 
to evaluate here.
In summary, among postmenopausal women with 
CRC, those with low social support had higher rates of 
overall and disease-specific mortality. Larger SNs and 
living with someone may confer a mortality benefit in 
patients with rectal cancer. Social support is important to 
prognosis in women with CRC, and clinicians should col-
lect information on social support in these patients, to link 
patients to resources and to consider whether clinical care 
might be modified to accommodate social support needs.
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